Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Supplied as a high-purity lyophilised peptide powder, this compound is intended strictly for controlled in-vitro research applications alongside our broader range of research peptides UK laboratories rely on
An Endogeous Defensive Concept, Renewed Cytoprotection/adaptive Cytoprotection: Intra(per)-Oral/intragastric strong Alcohol in Rat
General Safety Adults tolerate it well for both subcutaneous and intramuscular injection
In this comprehensive article well explore what FOXO4-DRI is, how it works, the current pre-clinical evidence, its promise and limitations, comparisons with other senolytic approaches, safety and regulatory considerations, and what the future might hold for integrating this novel peptide into a clinical strategy for healthier ageing
US$ 24.64
US$ 26.87
US$ 21.75
US$ 26.22
US$ 22.43
US$ 20.80